News Sentiment

GIS sentiment intelligence

Gilead Sciences, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 14 relevant articles
Exchange GER Germany
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 108.02 Week of 19 Jun 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

89/100 classification confidence.

Company focus 14

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+1.1% over one week, -5.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Gilead (NASDAQ: GILD) officer sells 3,000 shares under 10b5-1 plan

Market Reaction

Balanced read

66/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 89/100 classification
One-week reaction 1.1% Price digesting
Trend fit Trend inactive -5.1% over four weeks
Fair value 29.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 11
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 14
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 4
Market source 2
DirectorsTalk Interviews 1
CHEManager 1
TradingKey 1
Bloomberg.com 1
Reuters 1
Business Wire 1

Event Lens

What the news is about

Classified themes
Market update 12
Deals and strategy 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-14 of 14